The Hill looks at how pairing a GLP-1 drug with other treatment could bring added benefits for people living with psoriasis.
Recap by typeshit. Full story at The Hill.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Lilly says it has flagged over 14,000 listings and referred 200+ sellers to regulators. One analyst says illicit buyers pay about $200 a month.
A ticketed talk in Bergen County on eating, moving and keeping muscle while on a GLP-1. Event promotion with little news in it.
Loading…